Recruiting
Glaucoma Related Quality of Life
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
ClinicalTrials.gov IDNCT07510087
PhaseNot Applicable
Enrollment5000
SponsorMarc Toeteberg-Harms
Age18 Years
SexALL
Conditions studied
Glaucoma
About this study
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
Interventions
- Other: GQL-15 — GQL-15 questionnaire
- Other: Glaucoma Symptom Scale — GSS questionnaire
- Other: NEI Vision Function Questionnaire — Vision function questionnaire
- Other: Ocular Surface Disease Index — OSDI questionnaire
Primary outcomes
- Ocular Surface Disease Index (OSDI) (At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed.)
- Glaucoma Symptom Scale (GSS) (At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed.)
- National Eye Institute Visual Function Questionaire (NEI VFQ) (At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed.)
- Glaucoma Quality of Life-15 (GQL-15) (At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed.)
Eligibility information
Inclusion:
* diagnosis of glaucoma (open- as well as closed-angle glaucoma, primary and secondary glaucomas)
* 18 years of age or older with no upper limit
* male and female subjects
Exclusion:
* absence of a diagnosis of glaucoma
* less than 18 years of age
Study locations
- University of Iowa, Dept. of Ophthalmology & Visual Sciences, Iowa City, Iowa 52242 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.